Senior Associate / Manager – M&A and In-licensing

Since our establishment in 2008, we have built up our portfolio through the acquisition of princeps drugs from major pharmaceutical companies. We focus on essential medicines recognized by the medical community for their therapeutic value and ensure that they are produced, marketed, and promoted to healthcare professionals. By doing this, we help to improve the health of over 2.5 million patients worldwide every year.

Juvisé Pharmaceuticals is now an internationally recognized company whose neuroscience, gastroenterology, oncology, cardiology and rheumatology medicines are available in almost 80 countries worldwide.

Our team is built on a decentralized, high-performance model and concentrates on key, high-value-added functions, relying on a solid network of external partners.

In line with our corporate strategy and ambition to address unmet medical needs, we are accelerating our growth in 2024 by adding a drug indicated for the treatment of multiple sclerosis to our portfolio.

For further information, please visit juvisepharmaceuticals.com

As part of its development plan, and backed by its recent refinancing, Juvisé is strengthening its M&A team, which drives the company’s ambitious external growth strategy and shift towards innovation.

In this context, we are seeking a Senior Associate / Manager (3 to 6 years of experience) who will play a hands-on role in the identification, valuation, execution and negotiation of Juvisé’s next transactions, working closely with the leadership team.

• Identify and screen acquisition and in-licensing opportunities (market mapping, asset screening, first-level assessment)

• Maintain the M&A pipeline and contact tracking, and help manage relationships with pharma companies, biotechs and advisors (banks, brokers)

• Actively contribute to the execution of M&A transactions, and notably:

  • Perform in-depth assessments of targets (clinical value, market sizing, competitive landscape, pricing and market access) to support strategic decision-making

  • Build and own financial models and valuations (DCF, rNPV), including sensitivity and scenario analyses

  • Coordinate due diligence workstreams with internal experts (regulatory, medical, market access and pricing, supply chain, etc.) and external advisors

  • Support the review of transaction documentation (term sheets, licensing and purchase agreements) and the preparation of negotiations with counterparties

• Monitor industry transactions and strategic developments to extract key insights, and contribute to defining Juvisé’s growth strategy and key growth levers

Candidate profile

• 3 to 6 years of experience in strategy consulting, M&A, corporate finance, private equity and/or transaction services, including several years in pharma/life sciences

• Degree from a top-tier business or engineering school; a scientific background (e.g., PharmD, MD, life sciences) is a strong plus

• Strong financial modeling and valuation skills, including risk-adjusted approaches

• Ability to read and challenge clinical data with a strategic lens

• Strong analytical mindset, attention to detail and business acumen

• Ability to manage several complex projects in parallel and to prioritize in a fast-paced, demanding environment

• Intellectual curiosity, proactive mindset and a strong sense of ownership throughout all phases of a project

• Strong interpersonal skills, clear and structured communication (written and oral), and a positive, team-player attitude

• Fluent in English and French

What we offer

Compensation :

• A fixed salary paid over 13 months

• An individual bonus of up to 18%

• A profit-sharing scheme

• A progressive retention bonus

Employee benefits :

• 10 additional days off per year

• Up to 2 days of remote work per week

• Access to a sports and wellness programme (Gymlib)